Can the computer game TETRIS reduce symptoms of re-experiencing in patients suffering from Posttraumatic Stress Disorder?

The effect of trauma reactivation followed by a visuospatial intervention on intrusive symptoms in patients suffering from PTSD: a feasibility study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN34320836

Enrollment

Registered

2017-01-18

Start date

2015-04-16

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post traumatic stress disorder (PTSD) Mental and Behavioural Disorders Post traumatic stress disorder (PTSD)

Interventions

After two weeks of baseline (i.e., only assessing the number of intrusions via self-record intrusion diary), patients receive intervention sessions in the presence of a therapist or research assistant

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 18-65 2. Diagnosis of PTSD (ICD-10: F43.1) assessed clinically 3. Inpatient treatment (multimodal trauma-focused psychotherapy) at study facility

Exclusion criteria

Exclusion criteria: 1. Substance abuse or dependence within last 6 months 2. Acute suicidal tendency

Design outcomes

Primary

Measure	Time frame
Number of intrusions per week is measured by reviewing “intrusion diaries” kept daily by participants for the duration of their inpatient treatment (5-10 weeks).	—

Secondary

Measure	Time frame
1. PTSD symptom severity is measured using the Impact of Events Scale - Revised (IES-R) at baseline, and then weekly for the duration of inpatient treatment (5-10 weeks) 2. Depression is measured using the Beck Depression Inventory II (BDI-II) at baseline, and then weekly for the duration of inpatient treatment (5-10 weeks) 3. Anxiety is measured using the Beck Anxiety Inventory (BAI) at baseline, and then weekly for the duration of inpatient treatment (5-10 weeks)	—

Measure

Time frame

1. PTSD symptom severity is measured using the Impact of Events Scale - Revised (IES-R) at baseline, and then weekly for the duration of inpatient treatment (5-10 weeks) 2. Depression is measured using the Beck Depression Inventory II (BDI-II) at baseline, and then weekly for the duration of inpatient treatment (5-10 weeks) 3. Anxiety is measured using the Beck Anxiety Inventory (BAI) at baseline, and then weekly for the duration of inpatient treatment (5-10 weeks)

—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 4, 2026